Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Vikram Thermo (India)'s interest expense for the
three
months ended in Mar. 2026 was ₹ -1 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-5 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Vikram Thermo (India) Ltd has enough cash to cover all of its debt. Its financial situation is stable.
Vikram Thermo (India) Interest Expense Historical Data
* Premium members only.
The historical data trend for Vikram Thermo (India)'s Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vikram Thermo (India) (BOM:530477) has a Interest Expense of ₹-5 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Vikram Thermo (India) and its competitors.
Is Vikram Thermo (India)'s Interest Expense too high?
Vikram Thermo (India)'s current Interest Expense is ₹-5 Mil. Overall, Vikram Thermo (India) has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vikram Thermo (India)'s Interest Expense compare to ZTS?
Vikram Thermo (India)'s Interest Expense of ₹-5 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Vikram Thermo (India) and its competitors. Vikram Thermo (India)'s current Interest Expense is ₹-5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vikram Thermo (India) stock overvalued right now?
Based on GuruFocus' analysis, Vikram Thermo (India) (BOM:530477) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹183.49, compared to a current price of ₹263.15 — trading 43.4% above its estimated fair value. The current Interest Expense is ₹-5 Mil. Vikram Thermo (India)'s overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Vikram Thermo (India) (BOM:530477), the current Interest Expense is ₹-5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vikram Thermo (India) (BOM:530477) Overvalued in 2026?
Based on GuruFocus' analysis, Vikram Thermo (India) stock appears to be overvalued.
The current stock price of ₹263.15 is trading 43.4% above its estimated GF Value™ of ₹183.49.
GuruFocus considers Vikram Thermo (India) to be Significantly Overvalued.
Key valuation signals for BOM:530477:
Interest Expense: ₹-5 Mil
GF Value™: ₹183.49 vs. price of ₹263.15 (43.4% above fair value)
No single metric tells the full story. See the BOM:530477 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vikram Thermo (India) Ltd is engaged in the manufacturing and selling of basic pharma co-polymer Drug Coat, Diphenyl Oxide, Aquapol line of cosmetic polymers, and Apion line of cross-linked polymers. Through its products, the company provides a complete solution for various applications in the solid oral dosage coating segment with complementary technical support. It operates in a single segment, Chemicals. Geographically, the company generates maximum revenue from its business in India, followed by the Rest of the world.
80GF Score
Get the complete analysis for BOM:530477
Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530477 has been successfully added to your 
